Welcome to our dedicated page for NMAD news (Ticker: NMAD), a resource for investors and traders seeking the latest updates and insights on NMAD stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NMAD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NMAD's position in the market.
NOMAD Power Solutions (Nasdaq: NMAD), formerly LIXTE Biotechnology (Nasdaq: LIXT), completed its corporate name change and will begin trading under NMAD on July 6, 2026. Trading under LIXT ended July 2, 2026.
The new identity reflects a strategic shift into AI energy infrastructure equipment and services following the acquisition of NOMAD Transportable Power Systems. NOMAD offers patented, mobile, utility-grade battery energy storage systems serving AI and hyperscale data centers, utilities, industry, government and critical infrastructure via sales, rentals and Energy-as-a-Service. The company no longer plans to operate in its legacy life sciences market and is exploring options to sell or merge those assets.